DnB Asset Management AS Has $173.77 Million Stock Holdings in UnitedHealth Group Incorporated $UNH

Key Points

• DnB Asset Management AS increased its holdings in UnitedHealth Group by 22.5% in the first quarter, now owning 331,789 shares valued at approximately $173.77 million.
• Other institutional investors, like GAMMA Investing LLC and Vanguard Group Inc., have also significantly increased their stakes in UnitedHealth Group, contributing to a total institutional ownership of 87.86%.
• UnitedHealth Group recently announced its quarterly earnings, reporting a net margin of 5.04% and revenues of $111.62 billion, which were slightly below analysts' expectations.

DnB Asset Management AS raised its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 22.5% in the 1st quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 331,789 shares of the healthcare conglomerate's stock after acquiring an additional 61,031 shares during the quarter. UnitedHealth Group makes up approximately 0.8% of DnB Asset Management AS's holdings, making the stock its 23rd biggest position. DnB Asset Management AS's holdings in UnitedHealth Group were worth $173,774,000 at the end of the most recent quarter.

Other hedge funds have also added to or reduced their stakes in the company. GAMMA Investing LLC grew its stake in UnitedHealth Group by 56,142.1% in the first quarter. GAMMA Investing LLC now owns 8,295,153 shares of the healthcare conglomerate's stock valued at $4,344,586,000 after purchasing an additional 8,280,404 shares in the last quarter. Nuveen LLC acquired a new position in shares of UnitedHealth Group in the first quarter valued at approximately $3,846,764,000. Vanguard Group Inc. raised its stake in UnitedHealth Group by 6.6% in the 1st quarter. Vanguard Group Inc. now owns 90,729,585 shares of the healthcare conglomerate's stock worth $47,519,620,000 after purchasing an additional 5,583,343 shares in the last quarter. Wellington Management Group LLP lifted its position in shares of UnitedHealth Group by 10.6% during the 1st quarter. Wellington Management Group LLP now owns 25,847,940 shares of the healthcare conglomerate's stock valued at $13,537,859,000 after acquiring an additional 2,486,839 shares during the period. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC boosted its position in shares of UnitedHealth Group by 36.6% during the 4th quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 8,592,718 shares of the healthcare conglomerate's stock worth $4,346,712,000 after acquiring an additional 2,301,010 shares in the last quarter. Institutional investors own 87.86% of the company's stock.

Insider Buying and Selling

In other UnitedHealth Group news, CEO Patrick Hugh Conway sold 589 shares of the firm's stock in a transaction on Tuesday, June 10th. The shares were sold at an average price of $305.00, for a total value of $179,645.00. Following the completion of the transaction, the chief executive officer directly owned 10,398 shares of the company's stock, valued at $3,171,390. This trade represents a 5.36% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. 0.28% of the stock is currently owned by insiders.

UnitedHealth Group Stock Performance

NYSE UNH opened at $307.27 on Thursday. UnitedHealth Group Incorporated has a 52-week low of $234.60 and a 52-week high of $630.73. The company has a debt-to-equity ratio of 0.73, a quick ratio of 0.85 and a current ratio of 0.85. The company has a 50-day simple moving average of $288.51 and a 200 day simple moving average of $377.17. The company has a market capitalization of $278.29 billion, a PE ratio of 13.31, a price-to-earnings-growth ratio of 2.00 and a beta of 0.45.

UnitedHealth Group (NYSE:UNH - Get Free Report) last announced its quarterly earnings data on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share for the quarter, missing the consensus estimate of $4.45 by ($0.37). UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%.The firm had revenue of $111.62 billion during the quarter, compared to analysts' expectations of $111.75 billion. During the same period last year, the business posted $6.80 EPS. The company's revenue was up 12.9% compared to the same quarter last year. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. On average, research analysts predict that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 23rd. Investors of record on Monday, September 15th will be paid a dividend of $2.21 per share. The ex-dividend date of this dividend is Monday, September 15th. This represents a $8.84 annualized dividend and a yield of 2.9%. UnitedHealth Group's payout ratio is currently 38.30%.

Analysts Set New Price Targets

A number of research analysts have recently commented on the stock. Cantor Fitzgerald reissued an "overweight" rating and issued a $440.00 target price on shares of UnitedHealth Group in a report on Tuesday, August 26th. KeyCorp reduced their target price on shares of UnitedHealth Group from $400.00 to $350.00 and set an "overweight" rating on the stock in a report on Wednesday, July 30th. Wall Street Zen lowered shares of UnitedHealth Group from a "buy" rating to a "hold" rating in a report on Saturday, May 24th. TD Cowen lowered UnitedHealth Group from a "buy" rating to a "hold" rating and set a $308.00 target price for the company. in a research report on Monday, May 19th. Finally, Truist Financial lowered their price objective on UnitedHealth Group from $360.00 to $345.00 and set a "buy" rating for the company in a research report on Wednesday, July 16th. Fifteen analysts have rated the stock with a Buy rating, six have issued a Hold rating and three have issued a Sell rating to the stock. According to data from MarketBeat, UnitedHealth Group presently has a consensus rating of "Moderate Buy" and a consensus target price of $353.00.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.